Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Lunger John
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-18
Sale
2022-01-18
9:03 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
4,368 $3.1918 $13,942 7,336
(Direct)
View
2022-01-11
Sale
2022-01-13
9:02 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
4,846 $3.5539 $17,222 1,749
(Direct)
View
2022-01-04
Sale
2022-01-05
9:06 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,070 $4.0642 $4,349 1,755
(Direct)
View
2021-08-02
Sale
2021-08-02
5:09 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
2,939 $3.5848 $10,536 4,873
(Direct)
View
2021-07-02
Sale
2021-07-02
8:01 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,907 $4.2649 $8,133 3,170
(Direct)
View
2021-01-19
Sale
2021-01-19
9:01 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
4,358 $5.6695 $24,708 7,346
(Direct)
View
2021-01-12
Sale
2021-01-12
9:01 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,058 $6.1522 $6,509 1,767
(Direct)
View
2021-01-04
Sale
2021-01-05
9:02 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,065 $5.3279 $5,674 1,760
(Direct)
View
2020-08-03
Sale
2020-08-04
9:02 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
4,823 $9.25 $44,613 8,066
(Direct)
View
2020-01-14
Sale
2020-01-15
8:02 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,144 $5.1347 $5,874 1,681
(Direct)
View
2020-01-06
Sale
2020-01-07
8:01 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,148 $1.2 $1,378 1,677
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-03-03
Option Award
2022-03-07
6:14 pm
N/A
2032-03-03
GENOCEA BIOSCIENCES Inc GNCA Lunger John
Director
30,000 $0 30,000
(Direct)
View
2022-01-12
Option Award
2022-01-13
9:04 pm
N/A
2032-01-12
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,721,328 $0 1,721,328
(Direct)
View
2021-01-11
Option Award
2021-01-11
9:00 pm
N/A
2031-01-11
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,329,528 $0 1,329,528
(Direct)
View
2020-01-16
Option Award
2020-01-17
9:33 pm
N/A
2030-01-16
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,538,640 $0 1,538,640
(Direct)
View
2019-08-01
Option Award
2019-08-05
9:03 pm
N/A
2029-08-01
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,027,068 $0 1,027,068
(Direct)
View
2019-08-01
Ownership
2019-08-05
9:02 pm
N/A
N/A
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
0 $0 1,172,346
(Direct)
View